Intrathecal injection of HVJ‐E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats
Authors:
Open Access
- 20 November 2003
- journal article
- fj express-summarie
- Published by Wiley in The FASEB Journal
- Vol. 18 (1) , 212-214
Abstract
Hearing impairment, which is the most prevalent sensory deficit of human beings, needs a breakthrough in therapeutic technologies. One technology is the usage of a vector system to reach the inner ear, and another is by a therapeutic molecule. Here we developed a novel gene therapy strategy by combining hepatocyte growth factor (HGF) with hemagglutinating virus of Japan envelope (HVJ‐E) vector. When HVJ‐E containing human HGF gene was injected intrathecally into the cerebrospinal fluid via cisterna magna of rats, the vector reached the inner ear region, and human HGF gene expression was detected in the spiral ganglion cells (SGCs) of the inner ear. Expression of endogenous rat HGF and its receptor, c‐Met, was also induced in SGCs by human HGF. Kanamycin treatment results in hearing impairment by inducing degeneration of hair cells (HCs) and apoptosis of SGCs in rats. By HGF gene transfer before kanamycin treatment, both loss of HCs and apoptosis of SGCs were prevented. Furthermore, hearing function, evaluated by auditory brainstem response, was maintained at a normal level. When HGF gene transfer was performed 2 wk after kanamycin treatment, hearing impairment was significantly recovered. These results indicate a novel and effective therapeutic strategy against sensorineural hearing impairment.Keywords
Funding Information
- Ministry of Health
This publication has 50 references indexed in Scilit:
- The Functional and Structural Outcome of Inner Ear Gene Transfer via the Vestibular and Cochlear Fluids in MiceMolecular Therapy, 2001
- Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neuronsGene Therapy, 2001
- HSV Amplicon-Mediated Neurotrophin-3 Expression Protects Murine Spiral Ganglion Neurons from Cisplatin-Induced DamageMolecular Therapy, 2001
- Cochlear Gene Delivery through an Intact Round Window Membrane in MouseHuman Gene Therapy, 2001
- Safety of Adeno-Associated Virus as Cochlear Gene Transfer Vector: Analysis of Distant Spread Beyond Injected CochleaeMolecular Therapy, 2000
- Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, etsGene Therapy, 2000
- Inner Ear Transgene Expression after Adenoviral Vector Inoculation in the Endolymphatic SacHuman Gene Therapy, 1999
- Sustained Transgene Expression by Transfection of Renin Gene into Liver of NeonatesBiochemical and Biophysical Research Communications, 1996
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984
- Retrograde Degeneration of the Cochlear NerveActa Oto-Laryngologica, 1975